Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?

被引：79

作者：

Gault, VA ^{[1
]}

O'Harte, FPM ^{[1
]}

Flatt, PR ^{[1
]}

机构：

[1] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland

来源：

NEUROPEPTIDES | 2003年 / 37卷 / 05期

关键词：

D O I：

10.1016/j.npep.2003.09.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Glucose-dependent insulinotropic polypeptide (GIP or gastric inhibitory polypeptide) is a gastrointestinal hormone, which modulates physiological insulin secretion. Due to its insulinotropic activity, there has been a considerable increase of interest in utilising the hormone as a potential therapy for type 2 diabetes. One of the difficulties in attempting to harness the insulinotropic activity of GIP into an effective therapeutic agent is its short biological half-life in the circulation. However, recent years have witnessed the development of a substantial number of designer enzyme-resistant 'super GIP' molecules with potent insulinotropic and anti-diabetic properties. In addition, observations in transgenic GIP receptor deficient mice indicate that GIP directly links overnutrition to obesity, therein playing a crucial role in the development of obesity and related metabolic disorders. The present review aims to highlight the rapidly emerging potential therapeutic applications of GIP, and especially, enzyme-resistant GIP analogues. (C) 2003 Elsevier Ltd. All rights reserved.

引用

页码：253 / 263

页数：11

共 107 条

[41] Improved biological activity of Gly2- and Ser2-substituted analogues of glucose-dependent insulinotrophic polypeptide [J].

Gault, VA ;

Flatt, PR ;

Harriott, P ;

Mooney, MH ;

Bailey, CJ ;

O'Harte, FPM .

JOURNAL OF ENDOCRINOLOGY, 2003, 176 (01) :133-141

[42] Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide [J].

Gault, VA ;

Harriott, P ;

Flatt, PR ;

O'Harte, FPM .

BIOSCIENCE REPORTS, 2002, 22 (5-6) :523-528

[43] Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo [J].

Gault, VA ;

Parker, JC ;

Harriott, P ;

Flatt, PR ;

O'Harte, FPM .

JOURNAL OF ENDOCRINOLOGY, 2002, 175 (02) :525-533

[44] Enhanced cAMP generation and insulin-releasing potency of two novel Tyr1-modified enzyme-resistant forms of glucose-dependent insulinotropic polypeptide is associated with significant antihyperglycaemic activity in spontaneous obesity-diabetes [J].

Gault, VA ;

Flatt, PR ;

Bailey, CJ ;

Harriott, P ;

Greer, B ;

Mooney, MH ;

O'Harte, FPM .

BIOCHEMICAL JOURNAL, 2002, 367 :913-920

[45] Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide [J].

Gault, VA ;

O'Harte, FPM ;

Harriott, P ;

Flatt, PR .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (05) :1420-1426

[46] CLONING, FUNCTIONAL EXPRESSION, AND CHROMOSOMAL LOCALIZATION OF THE HUMAN PANCREATIC-ISLET GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR [J].

GREMLICH, S ;

PORRET, A ;

HANI, EH ;

CHERIF, D ;

VIONNET, N ;

FROGUEL, P ;

THORENS, B .

DIABETES, 1995, 44 (10) :1202-1208

[47] EFFECTS OF GASTRIC-INHIBITORY POLYPEPTIDE ON GLUCOSE AND LIPID-METABOLISM OF ISOLATED RAT ADIPOCYTES [J].

HAUNER, H ;

GLATTING, G ;

KAMINSKA, D ;

PFEIFFER, EF .

ANNALS OF NUTRITION AND METABOLISM, 1988, 32 (5-6) :282-288

[48] Structure-activity relationships of glucose-dependent insulinotropic polypeptide (GIP) [J].

Hinke, SA ;

Gelling, R ;

Manhart, S ;

Lynn, F ;

Pederson, RA ;

Kühn-Wache, K ;

Rosche, F ;

Demuth, HU ;

Coy, D ;

McIntosh, CHS .

BIOLOGICAL CHEMISTRY, 2003, 384 (03) :403-407

[49] Dipeptidyl peptidase IV-resistant [D-Ala2]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats [J].

Hinke, SA ;

Gelling, RW ;

Pederson, RA ;

Manhart, S ;

Nian, C ;

Demuth, HU ;

McIntosh, CHS .

DIABETES, 2002, 51 (03) :652-661

[50] Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP) [J].

Hinke, SA ;

Manhart, S ;

Pamir, N ;

Demuth, HU ;

Gelling, RW ;

Pederson, RA ;

McIntosh, CHS .

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2001, 1547 (01) :143-155

← 1 2 3 4 5 6 7 8 9 10 →